Why Goodwin Biotechnology?
Goodwin Biotechnology is a full-service, customer-focused and integrated contract services provider with a pioneering focus on the development and manufacturing of Cytotoxic Antibody Drug Conjugates (CADCs) from cell line development or exploratory proof-of-concept through process development, scale up, and cGMP manufacturing.
Goodwin Biotechnology leverages over 10 years of bioconjugation experience and expertise which complements our more than 20-year history in the development and manufacturing of mammalian cell culture-derived monoclonal antibodies, recombinant proteins and vaccines, making us one of the most experienced and stable contract manufacturing organizations (CMOs) in the world. Moreover, our global customer base which includes clients from North America, Europe as well as Asia, consists of companies ranging from academic institutions and biotechnology startup firms to large, established, multinational biopharmaceutical companies. Recognizing the challenges of manufacturing complex molecules such as CADCs, Goodwin Biotechnology will help to formulate a strategic approach to your project with an emphasis on critical development, manufacturing, quality, regulatory and characterization considerations.
For more information on Goodwin Biotechnology please fill in the form below.
Goodwin Biotechnology-- Your Single Source Solution™
To learn more, please click the following:
- Goodwin Biotechnology will Design and Execute your Process Development and Manufacturing Strategy
- Goodwin Biotechnology will Design and Execute your Formulation and Fill & Finish Strategy
- Goodwin Biotechnology will Design and Execute an Approach for Characterization of your Cytotoxic Antibody Drug Conjugate
- Goodwin Biotechnology will help Design your Regulatory Strategy